AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
CHIMERIC PAPILLOMAVIRUS VIRUS-LIKE PARTICLES ELICIT ANTITUMOR IMMUNITY AGAINST THE E7 ONCOPROTEIN IN AN HPV16 TUMOR-MODEL
Authors: GREENSTONE HL NIELAND JD DEVISSER KE DEBRUIJN MLH KIRNBAUER R RODEN RBS LOWY DR KAST WM SCHILLER JT
Citation: Hl. Greenstone et al., CHIMERIC PAPILLOMAVIRUS VIRUS-LIKE PARTICLES ELICIT ANTITUMOR IMMUNITY AGAINST THE E7 ONCOPROTEIN IN AN HPV16 TUMOR-MODEL, Proceedings of the National Academy of Sciences of the United Statesof America, 95(4), 1998, pp. 1800-1805
CHIMERIC L1 E2 AND L1/E6 VIRUS-LIKE PARTICLES FOR THE DEVELOPMENT OF A THERAPEUTIC PAPILLOMAVIRUS VACCINE/
Authors: DAURER W KIRNBAUER R
Citation: W. Daurer et R. Kirnbauer, CHIMERIC L1 E2 AND L1/E6 VIRUS-LIKE PARTICLES FOR THE DEVELOPMENT OF A THERAPEUTIC PAPILLOMAVIRUS VACCINE/, Journal of investigative dermatology, 110(4), 1998, pp. 484-484
DESMOGLEIN3-ELISA - A PEMPHIGUS VULGARIS-SPECIFIC DIAGNOSTIC-TOOL
Authors: LENZ P AMAGAI M VOLCPLATZER B STINGL G KIRNBAUER R
Citation: P. Lenz et al., DESMOGLEIN3-ELISA - A PEMPHIGUS VULGARIS-SPECIFIC DIAGNOSTIC-TOOL, Journal of investigative dermatology, 110(4), 1998, pp. 513-513
CICATRICIAL PEMPHIGOID WITH ANTI-EPILIGRI N AUTOANTIBODIES IN A PATIENT WITH METASTATIC ADENOCARCINOMA OF THE ENDOMETRIUM
Authors: LENZ P HSU R YEE C YANCEY K VOLCPLATZER B STINGL G KIRNBAUER R
Citation: P. Lenz et al., CICATRICIAL PEMPHIGOID WITH ANTI-EPILIGRI N AUTOANTIBODIES IN A PATIENT WITH METASTATIC ADENOCARCINOMA OF THE ENDOMETRIUM, Hautarzt, 49(1), 1998, pp. 31-35
ABSENCE OF P53 PROTEIN OVEREXPRESSION IN PRECANCEROUS LESIONS OF THE VULVA
Authors: KOHLBERGER PD KIRNBAUER R BANCHER D GITSCH G REINTHALLER A LEODOLTER S TSCHACHLER E KAINZ C BREITENECKER G
Citation: Pd. Kohlberger et al., ABSENCE OF P53 PROTEIN OVEREXPRESSION IN PRECANCEROUS LESIONS OF THE VULVA, Cancer, 82(2), 1998, pp. 323-327
CHARACTERIZATION OF A HUMAN PAPILLOMAVIRUS TYPE-16 VARIANT-DEPENDENT NEUTRALIZING EPITOPE
Authors: RODEN RBS ARMSTRONG A HADERER P CHRISTENSEN ND HUBBERT NL LOWY DR SCHILLER JT KIRNBAUER R
Citation: Rbs. Roden et al., CHARACTERIZATION OF A HUMAN PAPILLOMAVIRUS TYPE-16 VARIANT-DEPENDENT NEUTRALIZING EPITOPE, Journal of virology, 71(8), 1997, pp. 6247-6252
CHARACTERIZATION OF A HUMAN-PAPILLOMAVIRUS (HPV) TYPE-16 VARIANT-DEPENDENT NEUTRALIZING EPITOPE
Authors: KIRNBAUER R ARMSTRONG A HADERER P CHRISTENSEN N LOWY D SCHILLER J RODEN R
Citation: R. Kirnbauer et al., CHARACTERIZATION OF A HUMAN-PAPILLOMAVIRUS (HPV) TYPE-16 VARIANT-DEPENDENT NEUTRALIZING EPITOPE, Journal of investigative dermatology, 109(3), 1997, pp. 414-414
IDENTIFICATION OF A NEUTRALIZING EPITOPE OF THE HIGH-RISK HUMAN PAPILLOMAVIRUS (HPV) TYPE-16
Authors: KIRNBAUER R ARMSTRONG A HADERER P CHRISTENSEN N LOWY D SCHILLER J RODEN R
Citation: R. Kirnbauer et al., IDENTIFICATION OF A NEUTRALIZING EPITOPE OF THE HIGH-RISK HUMAN PAPILLOMAVIRUS (HPV) TYPE-16, Journal of investigative dermatology, 108(4), 1997, pp. 18-18
SERUM ANTIBODIES TO HPV-16 VIRUS-LIKE PARTICLES ARE NOT ASSOCIATED WITH PENILE CANCER IN CHINESE MALES
Authors: WIDEROFF L SCHIFFMAN M HUBBERT N KIRNBAUER R SCHILLER J GREER C MANOS MM DAWSEY SM JUNYAO L BRINTON L
Citation: L. Wideroff et al., SERUM ANTIBODIES TO HPV-16 VIRUS-LIKE PARTICLES ARE NOT ASSOCIATED WITH PENILE CANCER IN CHINESE MALES, Viral immunology, 9(1), 1996, pp. 23-25
PAPILLOMAVIRUS-LIKE PARTICLES FOR SEROLOGY AND VACCINE DEVELOPMENT
Authors: KIRNBAUER R
Citation: R. Kirnbauer, PAPILLOMAVIRUS-LIKE PARTICLES FOR SEROLOGY AND VACCINE DEVELOPMENT, Intervirology, 39(1-2), 1996, pp. 54-61
VIRUS-LIKE PARTICLES OF BOVINE PAPILLOMAVIRUS TYPE-4 IN PROPHYLACTIC AND THERAPEUTIC IMMUNIZATION
Authors: KIRNBAUER R CHANDRACHUD LM ONEIL BW WAGNER ER GRINDLAY GJ ARMSTRONG A MCGARVIE GM SCHILLER JT LOWY DR CAMPO MS
Citation: R. Kirnbauer et al., VIRUS-LIKE PARTICLES OF BOVINE PAPILLOMAVIRUS TYPE-4 IN PROPHYLACTIC AND THERAPEUTIC IMMUNIZATION, Virology, 219(1), 1996, pp. 37-44
IN-VITRO GENERATION AND TYPE-SPECIFIC NEUTRALIZATION OF A HUMAN PAPILLOMAVIRUS TYPE-16 VIRION PSEUDOTYPE
Authors: RODEN RBS GREENSTONE HL KIRNBAUER R BOOY FP JESSIE J LOWY DR SCHILLER JT
Citation: Rbs. Roden et al., IN-VITRO GENERATION AND TYPE-SPECIFIC NEUTRALIZATION OF A HUMAN PAPILLOMAVIRUS TYPE-16 VIRION PSEUDOTYPE, Journal of virology, 70(9), 1996, pp. 5875-5883
ASSESSMENT OF THE SEROLOGICAL RELATEDNESS OF GENITAL HUMAN PAPILLOMAVIRUSES BY HEMAGGLUTINATION INHIBITION
Authors: RODEN RBS HUBBERT NL KIRNBAUER R CHRISTENSEN ND LOWY DR SCHILLER JT
Citation: Rbs. Roden et al., ASSESSMENT OF THE SEROLOGICAL RELATEDNESS OF GENITAL HUMAN PAPILLOMAVIRUSES BY HEMAGGLUTINATION INHIBITION, Journal of virology, 70(5), 1996, pp. 3298-3301
IN-VITRO GENERATION OF INFECTIOUS PAPILLOMAVIRUS AND ASSESSMENT OF SEROLOGICAL CROSS-REACTIVITY
Authors: RODEN R KIRNBAUER R LOWY D SCHILLER J
Citation: R. Roden et al., IN-VITRO GENERATION OF INFECTIOUS PAPILLOMAVIRUS AND ASSESSMENT OF SEROLOGICAL CROSS-REACTIVITY, Journal of investigative dermatology, 107(3), 1996, pp. 8-8
IMMUNIZATION WITH VIRUS-LIKE PARTICLES PREVENTS BOVINE PAPILLOMAVIRUSTYPE-4 MUCOSAL INFECTION OF CALVES
Authors: KIRNBAUER R ONEIL B GRINDLAY J ARMSTRONG A LOWY D SCHILLER J CAMPO S
Citation: R. Kirnbauer et al., IMMUNIZATION WITH VIRUS-LIKE PARTICLES PREVENTS BOVINE PAPILLOMAVIRUSTYPE-4 MUCOSAL INFECTION OF CALVES, Journal of investigative dermatology, 106(4), 1996, pp. 234-234
EPIDEMIOLOGIC DETERMINANTS OF SEROREACTIVITY TO HUMAN PAPILLOMAVIRUS (HPV) TYPE-16 VIRUS-LIKE PARTICLES IN CERVICAL HPV-16 DNA-POSITIVE ANDDNA-NEGATIVE WOMEN
Authors: WIDEROFF L SCHIFFMAN MH HOOVER R TARONE RE NONNENMACHER B HUBBERT N KIRNBAUER R GREER CE LORINCZ AT MANOS MM GLASS AG SCOTT DR SHERMAN ME BUCKLAND J LOWY D SCHILLER J
Citation: L. Wideroff et al., EPIDEMIOLOGIC DETERMINANTS OF SEROREACTIVITY TO HUMAN PAPILLOMAVIRUS (HPV) TYPE-16 VIRUS-LIKE PARTICLES IN CERVICAL HPV-16 DNA-POSITIVE ANDDNA-NEGATIVE WOMEN, The Journal of infectious diseases, 174(5), 1996, pp. 937-943
SEROLOGY OF HUMAN PAPILLOMAVIRUS TYPE-16 INFECTIONS - WHERE ANGELS FEAR TO TREAD - REPLY
Authors: WIDEROFF L SCHILLER J KIRNBAUER R SCHIFFMAN MH TARONE RE MANOS MM LOWY D
Citation: L. Wideroff et al., SEROLOGY OF HUMAN PAPILLOMAVIRUS TYPE-16 INFECTIONS - WHERE ANGELS FEAR TO TREAD - REPLY, The Journal of infectious diseases, 174(1), 1996, pp. 238-239
SEROREACTIVITY TO HPV16 VIRUS-LIKE PARTICLES AS A MARKER FOR CERVICAL-CANCER RISK IN HIGH-RISK POPULATIONS
Authors: NONNENMACHER B KJAER SK SVARE EI SCOTT JD HUBBERT NL VANDENBRULE AJC KIRNBAUER R WALBOOMERS JMM LOWY DR SCHILLER JT
Citation: B. Nonnenmacher et al., SEROREACTIVITY TO HPV16 VIRUS-LIKE PARTICLES AS A MARKER FOR CERVICAL-CANCER RISK IN HIGH-RISK POPULATIONS, International journal of cancer, 68(6), 1996, pp. 704-709
LYMPHOPROLIFERATIVE RESPONSES TO BORRELIA-BURGDORFERI IN CIRCUMSCRIBED SCLERODERMA
Authors: BREIER F KLADE H STANEK G POITSCHEK C KIRNBAUER R DORDA W ABERER E
Citation: F. Breier et al., LYMPHOPROLIFERATIVE RESPONSES TO BORRELIA-BURGDORFERI IN CIRCUMSCRIBED SCLERODERMA, British journal of dermatology, 134(2), 1996, pp. 285-291
PROSPECTIVE-STUDY ON THE DEVELOPMENT OF ANTIBODIES AGAINST HUMAN PAPILLOMAVIRUS TYPE-6 AMONG PATIENTS WITH CONDYLOMA ACUMINATA OR NEW ASYMPTOMATIC INFECTION
Authors: WIKSTROM A VANDOORNUM GJJ KIRNBAUER R QUINT WGV DILLNER J
Citation: A. Wikstrom et al., PROSPECTIVE-STUDY ON THE DEVELOPMENT OF ANTIBODIES AGAINST HUMAN PAPILLOMAVIRUS TYPE-6 AMONG PATIENTS WITH CONDYLOMA ACUMINATA OR NEW ASYMPTOMATIC INFECTION, Journal of medical virology, 46(4), 1995, pp. 368-374
PAPILLOMAVIRUS L1 CAPSIDS AGGLUTINATE MOUSE ERYTHROCYTES THROUGH A PROTEINACEOUS RECEPTOR
Authors: RODEN RBS HUBBERT NL KIRNBAUER R BREITBURD F LOWY DR SCHILLER JT
Citation: Rbs. Roden et al., PAPILLOMAVIRUS L1 CAPSIDS AGGLUTINATE MOUSE ERYTHROCYTES THROUGH A PROTEINACEOUS RECEPTOR, Journal of virology, 69(8), 1995, pp. 5147-5151
IMMUNIZATION WITH VIRUS-LIKE PARTICLES FROM COTTONTAIL RABBIT PAPILLOMAVIRUS (CRPV) CAN PROTECT AGAINST EXPERIMENTAL CRPV INFECTION
Authors: BREITBURD F KIRNBAUER R HUBBERT NL NONNENMACHER B TRINDINHDESMARQUET C ORTH G SCHILLER JT LOWY DR
Citation: F. Breitburd et al., IMMUNIZATION WITH VIRUS-LIKE PARTICLES FROM COTTONTAIL RABBIT PAPILLOMAVIRUS (CRPV) CAN PROTECT AGAINST EXPERIMENTAL CRPV INFECTION, Journal of virology, 69(6), 1995, pp. 3959-3963
TYPE-SPECIFICITY OF THE IMMUNE-RESPONSE TO PAPILLOMAVIRUS-LIKE PARTICLES IN PATIENTS WITH RECURRENT RESPIRATORY
Authors: CHARVAT B SHAH K MOUNTS P KASHIME H LOWY D SCHILLER J KIRNBAUER R
Citation: B. Charvat et al., TYPE-SPECIFICITY OF THE IMMUNE-RESPONSE TO PAPILLOMAVIRUS-LIKE PARTICLES IN PATIENTS WITH RECURRENT RESPIRATORY, Journal of investigative dermatology, 105(3), 1995, pp. 496-496
EVALUATION OF SEROREACTIVITY TO HUMAN PAPILLOMAVIRUS TYPE-16 VIRUS-LIKE PARTICLES IN AN INCIDENT CASE-CONTROL STUDY OF CERVICAL NEOPLASIA
Authors: WIDEROFF L SCHIFFMAN MH NONNENMACHER B HUBBERT N KIRNBAUER R GREER CE LOWY D LORINCZ AT MANOS MM GLASS AG SCOTT DR SHERMAN ME KURMAN RJ BUCKLAND J TARONE RE SCHILLER J
Citation: L. Wideroff et al., EVALUATION OF SEROREACTIVITY TO HUMAN PAPILLOMAVIRUS TYPE-16 VIRUS-LIKE PARTICLES IN AN INCIDENT CASE-CONTROL STUDY OF CERVICAL NEOPLASIA, The Journal of infectious diseases, 172(6), 1995, pp. 1425-1430
DIVERGENT HUMAN PAPILLOMAVIRUS TYPE-16 VARIANTS ARE SEROLOGICALLY CROSS-REACTIVE
Authors: CHENG G ICENOGLE JP KIRNBAUER R HUBBERT NL STLOUIS ME HAN CL SVARE EI KJAER SK LOWY DR SCHILLER JT
Citation: G. Cheng et al., DIVERGENT HUMAN PAPILLOMAVIRUS TYPE-16 VARIANTS ARE SEROLOGICALLY CROSS-REACTIVE, The Journal of infectious diseases, 172(6), 1995, pp. 1584-1587
Risultati: 1-25 | 26-38